|
DHX16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.821200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.595000E-01 |
| Normal-vs-Stage2 |
3.886200E-01 |
| Normal-vs-Stage3 |
1.038580E-01 |
| Normal-vs-Stage4 |
7.096600E-01 |
| Stage1-vs-Stage2 |
4.182400E-01 |
| Stage1-vs-Stage3 |
9.342400E-02 |
| Stage1-vs-Stage4 |
5.715400E-01 |
| Stage2-vs-Stage3 |
7.203600E-01 |
| Stage2-vs-Stage4 |
3.402200E-01 |
| Stage3-vs-Stage4 |
1.714410E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.016200E-01 |
| Normal-vs-AfricanAmerican |
7.726800E-01 |
| Normal-vs-Asian |
3.159800E-02 |
| Caucasian-vs-AfricanAmerican |
9.534800E-01 |
| Caucasian-vs-Asian |
3.696900E-03 |
| AfricanAmerican-vs-Asian |
5.094500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.603800E-01 |
| Normal-vs-Female |
3.902800E-01 |
| Male-vs-Female |
5.399000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.939200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.343400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.872400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.779800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.745000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.917810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.370600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.250600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.243400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.618000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.384100E-02 |
| Classical-VS-Follicular |
2.516700E-03 |
| Classical-VS-Other |
8.767600E-01 |
| Classical-VS-Normal |
5.817200E-01 |
| Tall-VS-Follicular |
9.471600E-01 |
| Tall-VS-Other |
5.959000E-01 |
| Tall-VS-Normal |
5.245500E-02 |
| Follicular-VS-Other |
4.658800E-01 |
| Follicular-VS-Normal |
3.133600E-02 |
| Other-VS-Normal |
9.667400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.171800E-01 |
| Normal-vs-N1 |
4.856600E-01 |
| N0-vs-N1 |
2.009200E-01 |
|
|
